• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up2.00% Nasdaq Up1.66%

    Regeneron Pharmaceuticals, Inc. (REGN)

    -NasdaqGS
    379.01 Up 11.77(3.20%) Feb 12, 4:00PM EST
    |After Hours : 379.09 Up 0.08 (0.02%) Feb 12, 5:04PM EST
    Analyst OpinionGet Analyst Opinion for:
    Recommendation Summary*
    Mean Recommendation (this week):2.2
    Mean Recommendation (last week):2.2
    Change:0.0

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Price Target Summary
    Mean Target:523.29
    Median Target:525.00
    High Target:668.00
    Low Target:400.00
    No. of Brokers:21

    Data provided by Thomson/First Call

    Upgrades & Downgrades History
    DateResearch FirmActionFromTo
    Jan 27, 2016Canaccord GenuityDowngradeBuyHold
    Jan 25, 2016Chardan Capital MarketsDowngradeNeutralSell
    Jan 20, 2016Credit SuisseInitiated Neutral
    Oct 2, 2015Morgan StanleyDowngradeOverweightEqual-Weight
    Sep 1, 2015Raymond JamesInitiated Outperform
    Aug 31, 2015Chardan Capital MarketsDowngradeBuyNeutral
    Jul 22, 2015Northland CapitalInitiated Market Perform
    Mar 20, 2015Chardan Capital MarketsInitiated Buy
    Feb 19, 2015ROTH CapitalDowngradeBuyNeutral
    Jul 21, 2014ArgusInitiated Buy

    More Upgrades & Downgrades for REGN

    Data provided by Briefing.com - Take a free trial
    Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

    Recommendation Trends
    Current MonthLast MonthTwo Months AgoThree Months Ago
    Strong Buy9988
    Buy4444
    Hold99910
    Underperform0000
    Sell0000

    Data provided by Thomson/First Call


    Currency in USD.